Prosperico Ventures

Cytocares Technology specializes in the research and development of innovative macromolecule drugs aimed at tumor immunotherapy. The company focuses on creating novel medications that enhance tumor immunity, targeting both hematological tumors and solid tumors. By leveraging advanced drug design techniques, Cytocares strives to provide effective treatments and therapeutic options for patients facing various types of tumors, contributing to the advancement of cancer care.

Jiaohong Biology specializes in molecular diagnostic technology, focusing on the development and application of clinical diagnostic kits and automated diagnostic equipment. The company offers services that promote advancements in precise tumor diagnosis, nucleic acid detection for epidemic viruses, as well as for animal and plant diseases. Additionally, Jiaohong Biology addresses food safety concerns through its diagnostic solutions. Its innovative products aim to provide accurate diagnostic capabilities, supporting various industries in enhancing their diagnostic processes.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.

Singlera Genomics Inc. is a biotechnology company that specializes in genetic testing and molecular diagnostic technologies. Founded in 2014 and headquartered in La Jolla, California, with additional operations in Shanghai, China, Singlera develops a methylation detection platform designed for early cancer diagnosis and prevention. The company offers a range of services, including tumor diagnosis, personalized treatment, non-invasive prenatal diagnosis, and pre-implantation genetic screening. Additionally, Singlera is focused on advancing precision medicine, aiming to provide patients with early, accurate, and informative diagnostic solutions to improve healthcare outcomes.

Silexon is an AI-driven company focused on drug research and development, specializing in the integration of extensive drug-related data through artificial intelligence methodologies. The company offers a range of services aimed at enhancing the drug development process, including the creation of drug target panorama reports, personalized cell therapy solutions, and small molecule virtual screening. Additionally, Silexon provides advanced AI technologies such as drug repositioning platforms and macro-molecular design models to support pharmaceutical researchers in the generic drug discovery process. By delivering technical and AI-based data analysis, Silexon aims to streamline and improve the efficiency of drug development for pharmaceutical companies.

Its main business scope is medical device technology development and sales; biomedical technology development, technology transfer, technical consulting services; corporate marketing planning; market research; business information consulting; Management consulting services; self-operated and agent import and export business of various commodities and technologies.

Infinovo, established in 2016, specializes in the development of advanced biosensors and application products for the healthcare sector, particularly focusing on chronic disease detection and management. The company is dedicated to creating accurate and affordable Continuous Glucose Monitoring (CGM) systems for patients with Type 1 and Type 2 diabetes. Infinovo's CGM technology is designed to compete globally in terms of accuracy, durability, and design, aiming to enhance diagnostic precision and improve treatment outcomes for users. By providing innovative sensor tools, Infinovo seeks to facilitate better healthcare solutions for individuals managing chronic conditions.

Wolfman Medical Technology is a medical imaging equipment developer dedicated to medical imaging technology and brain

Xynomic Pharmaceuticals is dedicated to in-licensing, developing, and commercializing oncology drug candidates across China, the United States, and other global markets. The company's founders bring extensive experience from leading multinational biopharmaceutical firms, such as Schering, Eli Lilly, Merck, and Roche, where they held research and development roles. They also possess a proven track record of founding and successfully exiting biopharmaceutical ventures that bridge the US and China. Xynomic aims to establish a robust pipeline of clinical and pre-clinical stage oncology treatments, specifically targeting cancers that have high prevalence rates in these regions. By leveraging global resources, the company seeks to enhance the efficiency of drug development, both in terms of cost and time.

Singlera Genomics Inc. is a biotechnology company that specializes in genetic testing and molecular diagnostic technologies. Founded in 2014 and headquartered in La Jolla, California, with additional operations in Shanghai, China, Singlera develops a methylation detection platform designed for early cancer diagnosis and prevention. The company offers a range of services, including tumor diagnosis, personalized treatment, non-invasive prenatal diagnosis, and pre-implantation genetic screening. Additionally, Singlera is focused on advancing precision medicine, aiming to provide patients with early, accurate, and informative diagnostic solutions to improve healthcare outcomes.

Fourier Intelligence is a Shanghai-based technology and design company that specializes in the development of exoskeleton robotic products and services aimed at rehabilitation and orthoses. The company offers advanced robotics technology, including upper-limb rehabilitation robotics and lower-limb exoskeletons, which assist individuals with disabilities in overcoming physical limitations, enabling them to stand and walk again. Its innovative products not only enhance the quality of life for users but also improve productivity by reducing fatigue and facilitating the transportation of heavy objects in various sectors. Fourier Intelligence is committed to advancing healthcare and rehabilitation through its pioneering technologies, empowering individuals to regain mobility and independence.

Chao Ju Ophthalmology Hospital is a prominent healthcare provider specializing in ophthalmic treatments, particularly laser and refractive eye surgeries. Established in 1988 and headquartered in China, the hospital boasts over 30 years of operational experience in the field of ophthalmology. With a workforce exceeding 2,000 professionals, including professors, researchers, and senior medical practitioners, Chao Ju Ophthalmology is recognized for its strong technical expertise. The organization operates more than 100 medical clinics staffed by clinical professors, ensuring high-quality care and advanced treatment options for patients.

U-Dental is a prominent dental chain clinic operator in China, specializing in a wide range of oral care services. The company offers comprehensive dental treatments, including dental implants, orthodontic care, root canal therapy, periodontal treatment, and cosmetic dentistry. U-Dental aims to enhance the quality of dental care by providing a friendly and supportive environment for its patients. Additionally, the company fosters strong relationships with various international dental brands, allowing it to deliver advanced oral treatments that meet global standards. Through its commitment to quality and patient satisfaction, U-Dental seeks to improve the overall dental health of individuals across China.

Thoth Medical specializes in developing medical wearables that integrate biomedical sensor technology. Their platform focuses on continuous cardiac and maternal health assessment, featuring flexible biosensor materials, AI-driven arrhythmia detection, wireless data transmission, waterproofing, rechargeable designs, and compatibility with telemedicine workflows.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.